Abelleira E - Search Results

1

Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancer.

Pitoia F, Trimboli P, Abelleira E. Pitoia F, et al. Among authors: abelleira e. Endocrine. 2024 Oct;86(1):109-113. doi: 10.1007/s12020-024-03890-5. Epub 2024 May 27. Endocrine. 2024. PMID: 38801596

2

Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer.

Jerkovich F, Capalbo S, Abelleira E, Pitoia F. Jerkovich F, et al. Among authors: abelleira e. Endocrine. 2024 Aug;85(2):817-826. doi: 10.1007/s12020-024-03867-4. Epub 2024 May 21. Endocrine. 2024. PMID: 38772990

3

Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.

Pitoia F, Abelleira E, Román-González A, Danilovic DLS, Scheffel RS, Maia AL, Hoff AO, Califano I. Pitoia F, et al. Among authors: abelleira e. Thyroid. 2024 Jul;34(7):949-952. doi: 10.1089/thy.2024.0090. Epub 2024 Jun 3. Thyroid. 2024. PMID: 38757613

4

Dynamic risk assessment in patients with differentiated thyroid cancer.

Abelleira E, Jerkovich F. Abelleira E, et al. Rev Endocr Metab Disord. 2024 Feb;25(1):79-93. doi: 10.1007/s11154-023-09857-7. Epub 2023 Nov 28. Rev Endocr Metab Disord. 2024. PMID: 38015344 Review.

5

Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience.

Bueno F, Smulever A, Califano I, Guerra J, Del Grecco A, Carrera JM, Giglio R, Rizzo M, Lingua A, Voogd A, Negueruela MDC, Abelleira E, Pitoia F. Bueno F, et al. Among authors: abelleira e. Endocrine. 2023 Apr;80(1):134-141. doi: 10.1007/s12020-022-03295-2. Epub 2023 Jan 9. Endocrine. 2023. PMID: 36617605 Free PMC article.

6

Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study.

Jerkovich F, Abelleira E, Bueno F, Guerrero L, Pitoia F. Jerkovich F, et al. Among authors: abelleira e. Thyroid. 2022 Oct;32(10):1178-1183. doi: 10.1089/thy.2022.0302. Epub 2022 Sep 6. Thyroid. 2022. PMID: 35876426

7

Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment.

Abelleira E, Peñaloza MA, Jerkovich F, Bueno F, Pitoia F. Abelleira E, et al. Arch Endocrinol Metab. 2021 Nov 3;65(3):315-321. doi: 10.20945/2359-3997000000374. Arch Endocrinol Metab. 2021. PMID: 34731559 Free PMC article.

8

Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic.

Bueno F, Abelleira E, von Stecher F, de Lima AP, Pitoia F. Bueno F, et al. Among authors: abelleira e. Arch Endocrinol Metab. 2021 Nov 1;65(2):242-247. doi: 10.20945/2359-3997000000325. Epub 2021 Feb 15. Arch Endocrinol Metab. 2021. PMID: 33587835 Free PMC article.

9

Correction to: Dynamics of serum antithyroglobulin antibodies in patients with differentiated thyroid cancer.

Bueno F, Falcone MGG, Peñaloza MA, Abelleira E, Pitoia F. Bueno F, et al. Among authors: abelleira e. Endocrine. 2020 Oct;70(1):200-201. doi: 10.1007/s12020-020-02493-0. Endocrine. 2020. PMID: 32929581

10

Thyroid cancer in the Era of COVID-19.

Smulever A, Abelleira E, Bueno F, Pitoia F. Smulever A, et al. Among authors: abelleira e. Endocrine. 2020 Oct;70(1):1-5. doi: 10.1007/s12020-020-02439-6. Epub 2020 Aug 4. Endocrine. 2020. PMID: 32754886 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters